Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Biphenotypic, Acute × decitabine and cedazuridine drug combination × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 11 Myelodysplastic Syndromes 8 Leukemia, Myelomonocytic, Chronic 5 Myeloproliferative Disorders 4 Myelodysplastic-Myeloproliferative Diseases 2 Anemia, Refractory, with Excess of Blasts 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Systemic Mastocytosis With an Associated Hematologic Neoplasm 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Neurofibrosarcoma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Chronic-Phase 1 Hodgkin Disease 1 GATA2 Deficiency 1 Carcinoma, Merkel Cell 1 BRCA1 Mutation 1 Allogeneic Stem Cell Transplantation 1 Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

Cytarabine 11 fludarabine 10 Methotrexate 9 Cyclophosphamide 9 Specimen Handling 8 venetoclax 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 fludarabine phosphate 6 Stem Cell Transplantation 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 6 revumenib 5 merphos 5 Vincristine 5 Hydrocortisone 5 calaspargase pegol 4 blinatumomab 4 Spinal Puncture 4 Mesna 4 Melphalan 4 Dexamethasone 4 Busulfan 4 Biopsy 4 Azacitidine 4 prednylidene 3 dexamethasone acetate 3 dexamethasone 21-phosphate 3 deltacortene 3 Tacrolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡